A Research Paper on Treating Alzheimer’s Disease by NSAID

Abstract

Nonsteroidal calming drugs (NSAIDs) have been proposed for the potential treatment of neurodegenerative illnesses, for example, Alzheimer's infection (AD). Delayed utilization of NSAIDs, be that as it may, produces gastrointestinal (GI) poisonousness. To beat this genuine restriction, the point of this investigation was to create novel NSAID-determined medication forms (Anti-incendiary Lipoyl subordinates, AL4–9) that save the useful impacts of NSAIDS without messing GI up. As such, we formed chosen notable NSAIDs, for example, (S)- naproxen and (R)- flurbiprofen, with (R)- α-lipoic corrosive (LA) through alkylene diamine linkers.